Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05564273 · ClinicalTrials.gov registry record · NA

Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions

A NA study of Metabolic Health, sponsored by Viome.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05564273 is a NA study of Metabolic Health that is actively recruiting participants, run by Viome. The registered enrollment target is 150 participants, below the 50,130-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05564273, a NA study of Metabolic Health, is actively recruiting participants, sponsored by Viome.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

US residents who have obesity and sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will not utilize clinical sites.

Conditions Studied

Interventions

  • COMBINATION_PRODUCT VIOME Precision Nutrition Program
  • DIETARY_SUPPLEMENT VIOME-designed condition-based supplements

Study Locations (1)

Washington

  • Viome Life Sciences - Bothell

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-10-13
Est. Completion 2026-12
Phase NA

Sponsor

Viome

18 total trials

What the Registry Record Tells You About NCT05564273

The ClinicalTrials.gov registry entry for NCT05564273 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 50,130-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower). The listed sponsor is Viome, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Metabolic Health appearing as the primary indexed condition, and to 2 interventions - of which VIOME Precision Nutrition Program is the first listed.

NCT05564273 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT05564273 about?

NCT05564273 is a clinical study titled "Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions". US residents who have obesity and sign the informed consent form and are screened and enrolled for this study. Participants who are enrolled complete a survey upon enrollment and are randomized into one of three arms. This study is direct to participant and will not utilize clinical sites.

What is the current status of trial NCT05564273?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-10-13. Estimated completion is 2026-12.

What conditions does trial NCT05564273 study?

This clinical trial studies the following conditions: Metabolic Health.

What interventions are being tested in trial NCT05564273?

The interventions under investigation include: VIOME Precision Nutrition Program (COMBINATION_PRODUCT), VIOME-designed condition-based supplements (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05564273?

This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05564273 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.